Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

2.0K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.0K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.3K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K
Design Example: Analyzing Capacity Contours for Flood Risk Assessment01:17

Design Example: Analyzing Capacity Contours for Flood Risk Assessment

289
Flood risk assessment involves careful planning and analysis to ensure the safety of communities near water retention structures. Capacity contours are a vital tool in this process, as they illustrate the potential spread of water at specific levels in a given area. In the context of building a bund across a small valley, these contours play a critical role in evaluating the safety of nearby residential areas.In this example, the bund is intended to store stormwater in the valley. The engineers...
289
Cancer02:18

Cancer

53.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.7K
What is Cancer?02:12

What is Cancer?

14.0K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.0K
Cancer Vaccines01:30

Cancer Vaccines

984
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
984

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Margin Adequacy in Phyllodes Tumours Revisited: Reappraisal of the Evidence Base and Knowledge Gaps.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Same author

Disparities in Depression Among Older Asian, Native Hawaiian, and Pacific Islander Patients With Lung Cancer.

Cancer medicine·2026
Same author

Can whole genome data analysis be used to personalize breast cancer care?

Translational cancer research·2026
Same author

Association between indoor air pollution and risk of oesophageal cancer: a Chinese population-based case-control study.

BMJ public health·2026
Same author

Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancer.

NPJ precision oncology·2026
Same author

Prognostic significance of clinicopathological parameters, margin width and locoregional recurrences on outcome of primary and radiation associated breast angiosarcoma- results from a large UK sarcoma regional service.

Breast cancer research : BCR·2026
Same journal

Advancing Gastric Cancer Chemoprevention: Early Signals and Ongoing Challenges.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

Will they use it? Patient and provider acceptance of chatbot screening and counseling for hereditary cancer syndromes in a geographically underserved population.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

The Clinical Application of Refined Risk Estimates (caRe) Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

Simvastatin Treatment in Patients with Liver Cirrhosis: a Phase II Randomized Placebo Controlled Trial Shows Reduction in IL-6 Levels.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

A Neural Network-Enabled, Enzymatic cfDNA Methylation Assay for Colorectal Cancer Early Detection.

Cancer prevention research (Philadelphia, Pa.)·2026
Same journal

Comparative Analysis of Breast and Cervical Screening Adaptability at a Federally Qualified Health Center.

Cancer prevention research (Philadelphia, Pa.)·2026
See all related articles

Related Experiment Video

Updated: Jan 23, 2026

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
09:36

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

30.2K

Breast Hyperplasias, Risk Signature, and Breast Cancer.

Indira Poola1, Qingqi Yue2, John W Gillespie2

  • 1Silbiotech, Inc., Gaithersburg, Maryland. ipoola@silbiotech.com.

Cancer Prevention Research (Philadelphia, Pa.)
|June 27, 2019
PubMed
Summary
This summary is machine-generated.

A new four-marker panel accurately identifies high-risk patients with atypical and nonatypical hyperplasias. This molecular risk stratification aids in selecting patients for preventative therapies, potentially reducing sporadic breast cancers.

More Related Videos

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.9K
Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

4.6K

Related Experiment Videos

Last Updated: Jan 23, 2026

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats
09:36

Changes in Mammary Gland Morphology and Breast Cancer Risk in Rats

Published on: October 16, 2010

30.2K
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.9K
Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System
10:51

Modeling Breast Cancer in Human Breast Tissue using a Microphysiological System

Published on: April 23, 2021

4.6K

Area of Science:

  • Oncology
  • Molecular Diagnostics
  • Preventative Medicine

Background:

  • Oncologists lack molecular tools to stratify risk in patients with atypical and nonatypical hyperplasias.
  • Identifying high-risk individuals is crucial for administering effective preventative therapies.

Purpose of the Study:

  • To investigate a four-marker risk signature (MMP-1, CEACAM6, HYAL1, HEC1) for risk stratification.
  • To develop a "Cancer Risk Score" to identify patients who will benefit from preventative treatments.

Main Methods:

  • Assayed four markers (MMP-1, CEACAM6, HYAL1, HEC1) in 440 hyperplastic tissues using immunohistochemistry (IHC).
  • Combined marker expression levels to create a composite "Cancer Risk Score" (0-10).
  • Utilized Kaplan-Meier survival analysis to correlate risk scores with cancer rates at 5, 10, and 15 years.

Main Results:

  • The four-marker risk score achieved 91% accuracy for atypical and 86% for nonatypical hyperplasias.
  • Risk stratification identified low (≤0.5), intermediate (≤5.4), and high (>5.4) risk groups.
  • High-risk atypical and nonatypical subjects showed 5-year cancer rates of 73% and 34%, respectively, compared to 2% and 15% for low/intermediate groups.

Conclusions:

  • The developed molecular risk stratification accurately assesses tumor biology-based risk.
  • This approach enables informed treatment decisions for preventative therapies.
  • The findings suggest potential to prevent 20%-25% of sporadic breast cancers when combined with prophylactic measures.